Coming a step closer to understanding how gastric bypass works

October 5, 2017

A study by a team of researchers at the Massachusetts General Hospital Center for Engineering in Medicine (MGH-CEM) and Shriners Hospital for Children has made a technological advancement toward accelerating the discovery of drug targets for obesity, type II diabetes and other metabolic diseases. The novel experimental and computational workflow involves the first use of rodent gastric bypass models, state-of-the-art mass spectrometry and an array of bioinformatics tools to begin unraveling how gastric bypass surgery leads to weight loss and a resolution of type 2 diabetes. Their report on the impact of the surgery on liver metabolism appeared last month in the journal Technology.

"The therapeutic effects of gastric bypass give us hope that we can discover novel drugs for obesity and diabetes" says Nima Saeidi, PhD, of the MGH-CEM, principal investigator on the project. "Our goal is to reverse engineer the and resolution of blood sugar control without having to perform such an invasive procedure. To achieve this, we must first be able to capture how metabolic organs such as the liver, muscle, adipose tissue and even the small intestine reprogram themselves post-surgery to trigger the weight loss and reversal of insulin resistance"

To tackle this challenge, the team has been exploiting rapid advancements in to effectively quantify thousands of biomolecules, namely metabolites and proteins, in order to obtain clues about how specific tissues or whole organs respond to gastric bypass. In the present study, they utilized the state-of-the art SWATH proteomics workflow to discover approximately 100 proteins in rat livers, levels of which were significantly affected by Roux-en-Y gastric bypass (RYGB) surgery. These included proteins involved in iron transport, lipid metabolism and bile acid conjugation, some of which may be drugable targets for using a liver-specific version of the gene silencing technology RNAi. Having demonstrated the utility of this platform, the team plans to expand the analysis to study the effects of RYGB on multi-organ cross-talk via proteins secreted into the bloodstream.

Gautham Vivek Sridharan, PhD, the paper's lead author says, "We have finally reached a stage in biomedical research where we can interrogate complex in vivo systems by cost effectively acquiring large scale mRNA, protein and metabolite data. The challenge remains in the interpretation of these high-dimensional data to provide biological insight on how tissue-specific metabolic and signaling pathways are triggered by the surgery."

In the study, Sridharan pursued a network-based approach to integrate the protein and metabolite data to discover sub-networks or modules impacted by the surgery that may not have been intuitive based on conventional textbook pathways. He adds, "Going forward, developing network-based algorithms to handle time-series 'omics' data will be imperative for unraveling complex cause-and-effect relationships, such as the impact of post-surgery plasma hormone levels on tissue transcriptional reprogramming"

Martin Yarmush, MD, PhD, director of the MGH-CEM and co-corresponding author of the paper, stresses the multi-disciplinary nature of the work. "Investigators in the field have long sought after this type of multi-omic analysis on a rodent model to study metabolic disease, but the work required expertise in rodent surgery, multi-omic analytics, and computational biology. At the CEM, we enable engineering scientists to tackle complex problems in biomedicine at a world-class research hospital in collaboration with clinicians. This work will likely be of great interest to biotechnology companies aspiring to build their drug pipeline in the metabolic disease area."

Explore further: Long-term weight loss, T2DM remission for roux-en-Y surgery

More information: Gautham Vivek Sridharan et al, Multi-omic network-based interrogation of rat liver metabolism following gastric bypass surgery featuring SWATH proteomics, Technology (2017). DOI: 10.1142/S233954781750008X

Related Stories

Long-term weight loss, T2DM remission for roux-en-Y surgery

September 21, 2017
(HealthDay)—For patients with severe obesity, Roux-en-Y gastric bypass is associated with lasting benefits, according to a study published in the Sept. 21 issue of the New England Journal of Medicine.

Benefits of gastric bypass surgery linked to changes in sweet taste preference

July 18, 2017
Worldwide, the number of patients struggling with obesity is rapidly increasing in both adults and children. Diet and exercise are the mainstays of treatment for obesity, but have limited effectiveness. While bariatric surgery ...

Metabolic benefit same with similar weight loss after surgery

November 21, 2016
(HealthDay)—Early metabolic differences following laparoscopic adjustable gastric banding (LAGB) and Roux-en-Y gastric bypass (RYGB) in obese individuals with type 2 diabetes mellitus (T2DM) disappear when weight loss reaches ...

Could drugs replace gastric bypass surgery?

February 8, 2017
Gastric bypass surgery is one of the most successful treatments for obesity and related disorders; however, some patients may not want to undergo surgery.

Bariatric surgery found to reduce future health care costs

November 5, 2015
(HealthDay)—Gastric bypass surgery may save health care dollars down the road, a new study suggests. The findings were scheduled to be presented at ObesityWeek 2015, a meeting hosted by the American Society for Metabolic ...

Weight-loss surgery has low complication rates, study finds

November 6, 2014
(HealthDay)—People with type 2 diabetes who undergo a weight-loss procedure called laparoscopic gastric bypass surgery have a low risk for complications or death, according to a new study.

Recommended for you

Defining optimal opioid pain medication prescription length following surgery

September 27, 2017
A new study led by researchers at the Center for Surgery and Public Health at Brigham and Women's Hospital analyzed opioid prescription data from the Department of Defense Military Health System Data Repository, identifying ...

Is older blood OK to use in a transfusion?

September 27, 2017
(HealthDay)—Using older red blood cells to give transfusions to critically ill patients doesn't appear to affect their risk of dying, Australian researchers report.

One weight-loss surgery shows lasting results

September 21, 2017
(HealthDay)—Obesity surgery can have long-lasting effects on weight and the risk of developing type 2 diabetes and high blood pressure, a new study finds.

Hold the phone: An ambulance might lower your chances of surviving some injuries

September 20, 2017
Victims of gunshots and stabbings are significantly less likely to die if they're taken to the trauma center by a private vehicle than ground emergency medical services (EMS), according to results of a new analysis.

Surgeons have major influence on breast cancer treatment

September 13, 2017
A woman's choice of surgeon plays a significant role in whether she's likely to receive an increasingly popular aggressive breast cancer surgery.

Some thyroid cancer patients can safely delay surgery

September 4, 2017
Most people diagnosed with cancer want to start treatment as soon as possible, for fear that delaying care will allow their tumor to grow out of control.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.